Treo Ventures

08/16/2019 | Press release | Archived content

CVRx® Receives FDA Approval for World’s First Heart Failure Neuromodulation Device.

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Treo Ventures published this content on August 16, 2019, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 04, 2026 at 07:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]